Cited by 626Alzheimer's disease research and treatmentsSphingolipid Metabolism and SignalingDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Han, Xianlin, M. Holtzman, David, W. McKeel, Daniel, Kelley, John, Morris, John C.·2002·Journal of Neurochemistry

DOI 10.1046/j.1471-4159.2002.00997.x

Open this paper in CoChat — free account

Abstract

In addition to pathology in the gray matter, there are also abnormalities in the white matter in Alzheimer's disease (AD). Sulfatide species are a class of myelin‐specific sphingolipids and are involved in certain diseases of the central nervous system. To assess whether sulfatide content in gray and white matter in human subjects is associated with both the presence of Alzheimer's disease (AD) pathology as well as the stage of dementia, we analyzed the sulfatide content of brain tissue lipid extracts by electrospray ionization mass spectrometry from 22 subjects whose cognitive status at time of death varied from no dementia to very severe dementia. All subjects with dementia had AD pathology. The results demonstrate that: (i) sulfatides were depleted up to 93% in gray matter and up to 58% in white matter from all examined brain regions from AD subjects with very mild dementia, whereas all other major classes of lipid (except plasmalogen) in these subjects were not altered in comparison to those from age‐matched subjects with no dementia; (ii) there was no apparent deficiency in the biosynthesis of sulfatides in very mild AD subjects as characterized by the examination of galactocerebroside sulfotransferase activities in post‐mortem brain tissues; (iii) the content of ceramides (a class of potential degradation products of sulfatides) was elevated more than three‐fold in white matter and peaked at the stage of very mild dementia. The findings demonstrate that a marked decrease in sulfatides is associated with AD pathology even in subjects with very mild dementia and that these changes may be linked with early events in the pathological process of AD.

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2002.00997.x

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citation
Functions of Ceramide in Coordinating Cellular Responses to Stress
Hannun, Y. A. (1996) · Science · doi:10.1126/science.274.5294.1855 · Cited by 1,612
A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 879
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Self-citation
Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643
Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624

Show all 56 references

Research works printed but not linked: 5

10.1139/y59-099 · DOI · Paper page
10.1042/bj3520079 · DOI
Kolodny E. H., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2693
Mattson M. P., 1997, Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease, Trends Neurosci., 20, 373
Suzuki K., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2671

Sorted by citations

Items 501–600 of 625

Metabolomics in the Study of Alzheimer's Disease
Ibáñez, C., Valdés, A., García‐Cañas, V., & Simó, C. (2014) · Comprehensive analytical chemistry · doi:10.1016/b978-0-444-62650-9.00010-5 · Cited by 4
The potential role for sphingolipids in neuropathogenesis of Alzheimer’s disease
Alessenko, A. V. (2013) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750813020029 · Cited by 4
Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia
Svensson, J., Blomqvist, M., Kettunen, P., Eckerström, C., Henricsson, M., Jonsson, M. A. G., Bjerke, M., Månsson, J., & Wallin, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201552 · Cited by 4
Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer’s Disease-Related Genes
Liang, J., LaFleur, B., Hussainy, S., & Perry, G. L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221241 · Cited by 4
Sphingolipids: From structural components to signaling hubs
Issleny, B. M., Jamjoum, R., Majumder, S., & Stiban, J. (2023) · The Enzymes · doi:10.1016/bs.enz.2023.07.003 · Cited by 4
Apolipoprotein E genotype and LRP1 polymorphisms in patients with different clinical types of metachromatic leukodystrophy
Ługowska, A., Musielak, M., Jamroz, E., Pyrkosz, A., Kmieć, T., Tylki‐Szymańska, A., & Bednarska‐Makaruk, M. (2013) · Gene · doi:10.1016/j.gene.2013.05.009 · Cited by 4
Metabolic Syndrome as a Risk Factor for Alzheimer Disease
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_8 · Cited by 5
Integrating Omic Technologies in Alzheimer’s Disease
Avramouli, A., & Vlamos, P. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57379-3_16 · Cited by 4
Commentary: “Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?” By Claudio Costantini, Rekha M.K. Kolasani, and Luigi Puglielli
Casadesús, G., Smith, M. A., & Perry, G. L. (2005) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.06.011 · Cited by 4
Specific Lipid Alterations in Alzheimer’s Disease and Diabetes
Gross, R. W., & Han, X. (2005) · CRC Press eBooks · doi:10.1201/9781420027655.ch13 · Cited by 4
Self-citation
Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?
Correia, S. C., Perry, G. L., & Moreira, P. I. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240787 · Cited by 3
The role of sphingolipids in heart failure
Hamouche, R., Summers, S. A., Holland, W. L., Navankasattusas, S., Drakos, S. G., & Tseliou, E. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf035 · Cited by 6
Altered Composition of Ceramides and Sphingomyelin Distinctly Modulates the Organizational Landscape and Microdomain Dynamics of Neuronal Plasma Membrane: A Computational Microscopy of Alzheimer’s Brain
Peesapati, S., & Chakraborty, S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00261 · Cited by 2
Fingolimod normalizes metabolic signatures associated with synaptic plasticity and memory in APP/PS1 model: Sphingosine-1-phosphate receptor a therapeutic target for Alzheimer’s
Kalecký, K., Buitrago, L., Alarcón, J. M., Singh, A., Bottiglieri, T., Kaddurah‐Daouk, R., & Hernández, A. I. (2026) · Scientific Reports · doi:10.1038/s41598-026-42518-8 · Cited by 4
A Novel Non-Psychoactive Fatty Acid from a Marine Snail, Conus inscriptus, Signals Cannabinoid Receptor 1 (CB1) to Accumulate Apoptotic C16:0 and C18:0 Ceramides in Teratocarcinoma Cell Line PA1
Sathynathan, C. V., Lakshmisundaram, R., Surenderan, S., Kaur, H., Dandapani, M. C., Thyagarajan, S. P., & Gnanambal, K. M. E. (2024) · Molecules · doi:10.3390/molecules29081737 · Cited by 3
miR-137: A therapeutic candidate or a key molecular regulator in Alzheimer's disease?
Wasim, M., Guo, J., Wang, Z., Parveen, R., Chen, R., Wang, Y., & Ma, G. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251352166 · Cited by 3
DNA, Nuclear Cell Signaling and Neurodegeneration
Adams, J. D., Jr. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849733434-00175 · Cited by 3
The Role of Lipid Domains and Physical Properties of Membranes in the Development of Age-Related Neurodegenerative Diseases
Krasnobaev, V. D., & Batishchev, O. V. (2022) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s199074782209001x · Cited by 3
Neurochemical Aspects of Neurodegenerative Diseases
Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0_8 · Cited by 3
Metabolomic Fingerprinting of Blood Samples by Direct Infusion Mass Spectrometry: Application in Alzheimer’s Disease Research
González‐Domínguez, R. (2017) · Journal of Analysis and Testing · doi:10.1007/s41664-017-0018-4 · Cited by 4
High-Resolution Molecular Imaging and Its Applications in Brain and Synapses
Phan, N. T. N., & Rizzoli, S. O. (2020) · Neuromethods · doi:10.1007/978-1-0716-0691-9_3 · Cited by 3
Warfarin-induced vitamin K deficiency is associated with cognitive and behavioral perturbations, and alterations in brain sphingolipids in rats
Tamadon‐Nejad, S. (2013) · doi:10.71781/26836 · Cited by 3
Toward Total Cellular Lipidome Analysis by ESI Mass Spectrometry from a Crude Lipid Extract
Han, X., & Gross, R. W. (2005) · AOCS Publishing eBooks · doi:10.1201/9781439822319.ch12 · Cited by 3
Self-citation
The association of serum phospholipids levels with chronic kidney disease: A systematic review of observational studies
Asl, Z. S., Ghalichi, F., Badpeyma, M., & Ghoreishi, Z. (2024) · BioSocial Health Journal. · doi:10.34172/bshj.16 · Cited by 2
Profiling and semi-quantitation of urine sulfatides by UHPLC-Orbitrap-HRMS
van der Ham, M., van Konijnenburg, E. M. M. H., van Rossum, W., Gerrits, J., van Hasselt, P. M., Prinsen, H. C. M. T., Jans, J. J. M., Schlotawa, L., Laugwitz, L., & der Velden, M. G. M. D. S. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.343824 · Cited by 2
Comprehensive and high-coverage glycerophospholipidomic analysis based on iterative quadrupole time-of-flight mass spectrometry and its application in cerebral ischemia–reperfusion injury
Qu, B., Feng, M., Liu, L., Cong, S., Cai, S., Wang, T., Qiao, Y., Shi, L., Liu, J., & Xiao, H. (2025) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-025-05884-2 · Cited by 2
Sulfatide deficiency-induced astrogliosis and myelin lipid dyshomeostasis are independent of TREM2-mediated microglial activation
He, S., Mittra, N., Bao, H., Bhattacharjee, A., Dodds, S. G., Dupree, J. L., & Han, X. (2026) · Nature Communications · doi:10.1038/s41467-025-66222-9 · Cited by 4
Self-citation
Brain lipid profiles and oligodendrocyte gene expression show discordant responses to high-fat diet in Alzheimer’s disease mice
Kawade, N., Komine, O., Sobue, A., Kakimi, C., Tanaka, M., Suganami, T., Shimada, M., Ogi, T., Ikeda, K., Horiuchi, M., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-38129-y · Cited by 2
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 2
Arylsulfatase A: An Important Metabolic Factor in Pathophysiology of Different Diseases
Kovács, Z., Robert, T., Nagy, E. N., Victor, B. S., Mariana, T., Orsolya, M., & Fazakas, Z. (2015) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2015-0064 · Cited by 2
The impact of sulfatide loss on the progress of Alzheimer's disease
Finkielstein, C. V., & Capelluto, D. G. S. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.236 · Cited by 2
Lipid Metabolism: Key Determinant in Neurodegenerative Diseases
Yadav, M., Gupta, J., & Agrawal, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_6 · Cited by 2
Accelerated cognitive aging in chronically infected HIV-1 positive individuals despite effective long-term antiretroviral therapy
Babu, H., Rachel, G., Neogi, U., Palaniappan, A. N., Narayanan, A., Chinnaiyan, P., Sundaraj, V., Viswanathan, V. K., Kumar, C. P. G., Tripathy, S. P., et al. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01458-w · Cited by 3
Novel synthetic sulfoglycolipid IG 20 facilitates exocytosis in chromaffin cells through the regulation of sodium channels
Crespo‐Castrillo, A., Punzón, E., de Pascual, R., Maroto, M., Padín, J. F., García‐Álvarez, I., Nanclares, C., Ruiz‐Pascual, L., Gandı́a, L., Fernández‐Mayoralas, A., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13357 · Cited by 2
P2‐048: Plasma sphingomyelin is associated with cognitive progression in Alzheimer's Disease
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Weinberg, D. D., Zaidi, N., Pavlik, V., Doody, R. S., & Lyketsos, C. G. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.937 · Cited by 2
Beneficial Effects of Flaxseed Oil (n-3 Fatty Acids) on Neurological Disorders
Farooqui, A. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3804-5_3 · Cited by 2
Novel sulfoglycolipid IG20 causes neuroprotection by activating the phase II antioxidant response in rat hippocampal slices
Punzón, E., García‐Alvarado, F., Maroto, M., Fernández‐Mendívil, C., Michalska, P., García‐Álvarez, I., Arranz‐Tagarro, J. A., Buendía, I., López, M. G., Leon, R. M., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.016 · Cited by 2
Dietary Neurolipidomics in Alzheimer's Disease
Kalli, Ε. G., & Vlamos, P. (2022) · Journal of Nutritional Medicine and Diet Care · doi:10.23937/2572-3278/1510058 · Cited by 2
Mass Spectrometry Imaging Shows Modafinil, A Student Study Drug, Changes the Lipid Composition of the Fly Brain
Philipsen, M. H., Ranjbari, E., Gu, C., & Ewing, A. G. (2021) · Angewandte Chemie · doi:10.1002/ange.202105004 · Cited by 2
Correction to: Metabolomic Fingerprinting of Blood Samples by Direct Infusion Mass Spectrometry: Application in Alzheimer’s Disease Research
González‐Domínguez, R. (2017) · Journal of Analysis and Testing · doi:10.1007/s41664-017-0041-5 · Cited by 2
Current and Developing Methods for Diagnosing Alzheimer's Disease
Fuller, S. J., Carrigan, N., Sohrabi, H. R., & Martins, R. N. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch3 · Cited by 2
Lipotype acquisition during neural development in vivo is not recapitulated in stem cell-derived neuronsPreprint
Gopalan, A. B., van Uden, L., Sprenger, R. R., Marx, N. F.-N., Bogetofte, H., Neveu, P. A., Meyer, M., Noh, K., Diz-Muñoz, A., & Ejsing, C. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.31.505694 · Cited by 2
Functions of glycosphingolipids in the central nervous system
Guo, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16156-8.00005-5 · Cited by 1
Concussion-Related Cognitive and Lipid Changes in Retired UK Rugby Players Study
Alanazi, N., Robinson, T., Entwistle, I. R., Hind, K., & Chazot, P. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211002 · Cited by 1
Extracellular amyloid-β 42 oligomers alter endo-lysosomal trafficking of Rab7- and Lamp-1-coated vesicles in cultured neuroblastoma cells
Mendoza-Franco, G., Rodríguez‐Cruz, F., Estrada-Modesto, S., González, E. O. H., Boucard, A. A., Ríos, M. A. M., Basurto‐Islas, G., & García‐Sierra, F. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261422415 · Cited by 1
Dietary silver nanoparticle supplementation induces Alzheimer-like lesions through Bifidobacterium deficiency-dominated gut microbiota dysbiosis and neuroinflammation
Shou, R., Wang, Z., Han, Z., Li, A., Shang, J., Lou, H., Zhang, X., Zhan, Y., Shen, G., Lu, X., et al. (2026) · npj Science of Food · doi:10.1038/s41538-026-00820-9 · Cited by 1
Circulating lipids are related to longitudinal changes of ATN biomarkers for Alzheimer’s disease
Kim, J. P., Nho, K. T., Wang, T., Huynh, K., Arnold, M., Risacher, S. L., Bice, P. J., Han, X., Kristal, B. S., Blach, C., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03626-z · Cited by 6
Self-citation
Lipidomic profiling reveals age-dependent changes in plasma membrane lipids that affect neural stem cell aging
Zhao, X., Feitzinger, R. M., Na, J., Yan, X., Erickson, A., Contrepois, K., Zhou, O. Y., Vallania, F., Ellenberger, M., Kashiwagi, C. M., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeh9771 · Cited by 10
Protective Effect of Ginsenoside Rgl on H2O2-Induced Cell Death by the Decreased Ceramide Level in LLC-PK1 Cells
Lee, Y. (2006) · Journal of Ginseng Research · doi:10.5142/jgr.2006.30.1.001 · Cited by 1
Quantifying Interactions Between Lipids and Surfaces
Patra, A. (2016) · Springer theses · doi:10.1007/978-3-319-30728-2_4 · Cited by 1
Sulfatides Primarily Exist in the Substantia Nigra Region of Mouse Brain Tissue
Park, K. D., Shon, J. C., Kim, J., Park, G. H., Choi, H. J., & Liu, K. (2017) · Lipids · doi:10.1007/s11745-016-4224-z · Cited by 1
Electrical Stimulation of Brain Tissue with Carbon Nanofi ber Microbrush Arrays
(2012) · CRC Press eBooks · doi:10.1201/b11835-8 · Cited by 1
The Role of Lipid Domains and Physical Properties of Membranes in the Development of Age-Related Neurodegenerative Diseases
Krasnobaev, V. D., & Batishchev, O. V. (2023) · Биологические мембраны Журнал мембранной и клеточной биологии · doi:10.31857/s023347552301005x · Cited by 1
Lipid Metabolism in Neurodegenerative Diseases
Lim, L., Shui, G., & Wenk, M. R. (2012) · Wiley eBooks · doi:10.1002/9783527655946.ch14 · Cited by 2
Contribution of Phospholipid, Sphingolipids, and Cholesterol‐Derived Lipid Mediators in the Pathogenesis of Metabolic Syndrome and Neurological Disorders
Farooqui, A. A., & Farooqui, T. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch7 · Cited by 1
Oxidative Stress in Kainic Acid Neurotoxicity: Implications for the Pathogenesis of Neurotraumatic and Neurodegenerative Diseases
Farooqui, A. A. (2011) · doi:10.1002/9781118148143.ch4 · Cited by 1
Biomarkers to Advance Drug Development for Alzheimer‘s Disease
Schulman, H. (2006) · Future Neurology · doi:10.2217/14796708.1.4.409 · Cited by 1
Lipidomics for Health and Disease
(2016) · Wiley eBooks · doi:10.1002/9781119085263.ch17 · Cited by 1
Diet and Nutrition, and their Influence on Alzheimer's Disease and other Neurodegenerative Diseases
Rainey‐Smith, S. R., Creegan, R., Fuller, S. J., Callisaya, M. L., & Srikanth, V. K. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch5 · Cited by 1
Evaluation of BACE1 silencing as a therapy against Alzheimer disease: implications for lipid metabolism and inflammatory response
Villamil-Ortiz, J. G. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.99684546 · Cited by 1
Sulfatide deficiency-induced astrogliosis and myelin lipid dyshomeostasis are independent of Trem2-mediated microglial activationPreprint
Mittra, N., He, S., Bao, H., Bhattacharjee, A., Dodds, S. G., Dupree, J. L., & Han, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.14.623651 · Cited by 1
Self-citation
Rescue of hippocampal synaptic plasticity and memory performance by Fingolimod (FTY720) in APP/PS1 model of Alzheimer’s disease is accompanied by correction in metabolism of sphingolipids, polyamines, and phospholipid saturation compositionPreprint
Kalecký, K., Buitrago, L., Alarcón, J. M., Singh, A., Bottiglieri, T., Kaddurah-Daouk, R. F., & Hernandez, A. I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.17.633452 · Cited by 1
Defining the metabolic effect of peroxisome proliferator-activated receptor δ activation
Roberts, L. D. (2010) · Apollo (University of Cambridge) · doi:10.17863/cam.16521 · Cited by 2
EFECTO DE TIBOLONA SOBRE BIOMARCADORES ASOCIADOS A DETERIORO COGNITIVO LEVE EN PACIENTES MENOPAUSICAS
Hernández, S. F. (2011)
Role of Oxidatively Stressed Lipids in Amyloid Formation and Toxicity
Axelsen, P. H., & Komatsu, H. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch27
Analysis of Magnetic Resonance Imaging Data on the Study of Alzheimer’s Disease
Zhao, X., Zhi-Ying, L. O. N. G., Guo, X., & Li, Y. (2010) · Journal of Software · doi:10.3724/sp.j.1001.2009.03556
P1–090: FTY720/Fingolimod, a sphingosine analogue, reduces beta‐amyloid production in neurons
Takasugi, N., Sasaki, T., Tomita, T., & Iwatsubo, T. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.311
Shifting Our Focus to blood-based Biomarkers of Alzheimer’s Disease: the Promise of Ceramides and Sphingomyelins
Mielke, M. M. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.87
El 17-?-estradiol frente a la muerte apoptótica en neuronas granulares de cerebelo: efectos sobre la supervivencia y modulación de la plasticidad neuronal
Molina, M. A., & Jesús, A. (2007) · TDX (Tesis Doctorals en Xarxa)
23rd Marabou Symposium: Nutrition and the Aging Brain
James, W. P. T. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00349.x
Schizophrenia: Blood-Serum-Plasma Metabolomics
Lista, S., Giegling, I., & Rujescu, D. (2014) · Advances in biological psychiatry · doi:10.1159/000358024
Alterations in Raft Lipid Metabolism in Aging and Neurodegenerative Disorders
Mattson, M. P., Cutler, R. G., & Haughey, N. J. (2005) · Humana Press eBooks · doi:10.1385/1-59259-803-x:143
Vitamine K et fonctions cognitives chez la personne âgée en santé : une approche épidémiologique nutritionnelle
Presse, N. (2012) · doi:10.71781/28987
Current strategies in the discovery of small-molecule biomarkers for
Whiley, L. (2011)
Mechanisms of palmitate induced amyloidogenesis in Alzheimer's Disease mediated by astrocytes
Liu, L. (2013) · doi:10.25335/hzqa-1c05
Dietary cholesterol effects on learning, memory and amyloid beta: Learning and memory effects on brain cholesterol and sulfatide levels
Darwish, D. S. (2010) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3252
Comparative Lipidomic Analysis of Mouse and Human Brain
Chan, R., Oliveira, T. G., Cortes, E. P., Honig, L. S., Duff, K., Small, S. A., Wenk, M. R., Shui, G., & Paolo, G. D. (2012)
Myelin changes in Alzheimer's disease and its mechanism
Tang, X., Wu, D., & Zhang, Z. (2014)
Ramsey County Medical Society puts doctors on display.
Pj, K. (1989) · PubMed
GUMBOS as Matrices for Matrix-Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry
Ghafly, A., & Abdullah, H. (2015)
Contribution of Neural Membrane Phospholipids, Sphingolipids, and Cholesterol in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00003-3
Development of a bacterial adhesin into a next generation antimicrobial agent
Al-Saedi, F. M. A. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Efeito de aldeídos de colesterol na esclerose lateral amiotrófica: estudo em modelo animal e na agregação da SOD1 in vitro
Dantas, L. S. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2018.tde-24082018-104659
Sets of Co-regulated Serum Lipids are Associated with Alzheimer Disease PathophysiologyPreprint
Barupal, D. K., Bailli, R., Fan, S., Saykin, A. J., Meikle, P. J., Arnold, M., Nho, K. T., Fiehn, O., Kaddurah-Daouk, R. F., & Initiative, A. D. N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/550723
The Role of Human Coactosin-Like Protein in Neurodegenerative Disorders
Shanu, Y. A., Lauto, A., & Myers, S. J. (2017) · Biochemistry and Modern Applications · doi:10.33805/2638-7735.107
A study of the global effects of Apolipoprotein E using lipidomics
Hawksworth, J. I. (2019) · ORCA Online Research @Cardiff (Cardiff University)
The Propagation of Neurodegenerative Diseases by Inflammation and Exosomes
Sackmann, V. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-160949 · Cited by 1
Combining two large clinical cohorts (AIBL and ADNI) to identify multiple lipid metabolic pathways in prevalent and incident Alzheimer’s diseasePreprint
Huynh, K., Lim, W. L. F., Giles, C., Jayawardana, K. S., Salim, A., Mellett, N. A., Smith, A., Olshansky, G., Drew, B. G., Chatterjee, P., et al. (2020) · medRxiv · doi:10.1101/2020.05.26.20114215
Self-citation
Exploring sphingolipid function in the pathogenesis of Alzheimer’s disease
Luo, Q. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220215ql
The potential of extracellular vesicle lipid profiling in Alzheimer's disease.Preprint
Su, H., Masters, C. L., Bush, A. I., Barnham, K. J., Reid, G. E., & Vella, L. J. (2023) · doi:10.22541/au.168388562.25020996/v1
Metabolomics: Special Emphasis on Basic Drug Discovery and Development
Nath, D., & Chetia, D. (2023) · Pharmaceutical science. · doi:10.5772/intechopen.112969
α7 nicotinic acetylcholine receptors are necessary for basal forebrain activation to increase expression of the nerve growth factor receptor TrkAPreprint
Kumro, J., Tripathi, A., Terry, A. V., Pillai, A., & Blake, D. T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.01.582932
Microglia-Dependent and Independent Modulation of Brain Lipid Metabolism in Alzheimer’s Disease Revealed by Pharmacological and Genetic Microglial DepletionPreprint
Xu, Z., Shabestari, S. K., Barannikov, S., Bieniek, K. F., Blurton-Jones, M. M., Palavicini, J. P., & Han, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.18.624173
Self-citation
In vivo Protection of Vitamin K in NMDA-Induced Memory Impairment
Safarkhani, L., Taleghani, B. K., Ansar, M. M., & Rostampour, M. (2024) · Journal of Reports in Pharmaceutical Sciences · doi:10.5812/jrps-148544
Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass SpectrometerPreprint
Müller, E., Enzlein, T., Niemeyer, D., von Ammon, L., Stumpo, K. A., Biber, K., Klein, C., & Hopf, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.04.626756
Glycosphingolipids in Dementia: Insights from Mass Spectrometry and Systems Biology Approaches
Sârbu, M., Ică, R., Biricioiu, M. R., Dehelean, L., & Zamfir, A. D. (2025) · Biomedicines · doi:10.3390/biomedicines13122854
PKC-dependent MYRF dysregulation links Aβ pathology to oligodendrocyte, myelin and cognitive alterations in Alzheimer’s diseasePreprint
Balantzategi, U., Gaminde‐Blasco, A., Alcañiz, N., Ramírez, J., Senovilla-Ganzo, R., Hernández-Pinedo, N., Fernandez-Ballester, M., Soria, F. N., de la Fuente, A. G., García‐Moreno, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.09.693299
Additional file 3 of Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
Wang, N., Wang, M., Jeevaratnam, S., Rosenberg, C. L., Ikezu, T. C., Shue, F., Doss, S. V., Alnobani, A., Martens, Y. A., Wren, M. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21622301
Additional file 4 of Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
Wang, N., Wang, M., Jeevaratnam, S., Rosenberg, C. L., Ikezu, T. C., Shue, F., Doss, S. V., Alnobani, A., Martens, Y. A., Wren, M. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21622304
Additional file 2 of Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment
Qiu, S., Palavicini, J. P., Wang, J., Gonzalez, N. S., He, S., Dustin, E., Zou, C., Ding, L., Bhattacharjee, A., Skike, C. E. V., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16625144
Self-citation

Authors: Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Han, Xianlin
ORCID: Han, Xianlin
Morris, John C.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2002-08
Volume: 82
Issue: 4
Pages: 809-818
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1046/j.1471-4159.2002.00997.x
OpenAlex: W1594975246
Cited by: 626
References: 56
Citations by year: 2026: 24 · 2025: 26 · 2024: 29 · 2023: 32 · 2022: 32 · 2021: 29 · 2020: 32 · 2019: 22 · 2018: 29 · 2017: 33 · 2016: 34 · 2015: 24 · 2014: 33 · 2013: 33 · 2012: 36
FWCI: 7.61
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p41rr000954-34)
National Institute on Aging (P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991)
National Center for Research Resources (P41RR00954-240043)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, sulfatide, ceramide, white matter, gray matter, brain lipid composition, pathogenesis
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Chemistry, Ceramides, Dementia, Galactosylceramides, Humans, Neuropsychological Tests, Severity of Illness Index, Sphingomyelins, Sulfoglycosphingolipids, Sulfotransferases, Disease Progression, Spectrometry, Mass, Electrospray Ionization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks